Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

973
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

30
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic...
30
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical and clinical performance of the updated Elecsys Anti-TPO II assay for the detection of antibodies against thyroid peroxidase to aid in the diagnosis of autoimmune thyroid diseases.

Clinical chemistry and laboratory medicine·2026
Same author

Peak oxygen consumption is positively associated with estimates of oxygen extraction and microvascular blood volume in veterans with chronic kidney disease.

American journal of physiology. Renal physiology·2026
Same author

Enhancing research ethics and protections for uninsured and underinsured research participants in clinical trials in the USA.

Journal of clinical and translational science·2026
Same author

Differentiated Thyroid Cancer Is Associated With Sex-specific Immune Response.

Journal of the Endocrine Society·2025
Same author

Update in Papillary Thyroid Cancer.

Endocrinology and metabolism clinics of North America·2025
Same author

Thyroid Cancer: An Update in Causal Mechanisms, Diagnosis, Initial Treatment, and Long-Term Management.

Endocrinology and metabolism clinics of North America·2025

Related Experiment Video

Updated: May 3, 2026

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

19.4K

A diagnostic scoring system for myxedema coma.

Geanina Popoveniuc1, Tanu Chandra2, Anchal Sud3

  • 1Division of Endocrinology, Department of Medicine, MedStar Washington Hospital Center, Washington DC Division of Endocrinology, Department of Medicine, Georgetown University Hospital, Washington DC.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|February 13, 2014
PubMed
Summary
This summary is machine-generated.

A new scoring system aids in diagnosing myxedema coma (MC), a severe form of hypothyroidism. A score of 60 or higher suggests MC, while scores between 45-59 indicate patients at risk.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

7.2K

Related Experiment Videos

Last Updated: May 3, 2026

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

19.4K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

7.2K

Area of Science:

  • Endocrinology
  • Internal Medicine
  • Critical Care Medicine

Background:

  • Myxedema coma (MC) is a life-threatening decompensated state of extreme hypothyroidism.
  • Early recognition and treatment are crucial due to high mortality rates.
  • Diagnostic criteria for MC are not well-established, hindering timely intervention.

Purpose of the Study:

  • To develop and validate a diagnostic scoring system for myxedema coma.
  • To facilitate earlier identification and treatment of MC.
  • To improve patient outcomes by establishing clear diagnostic criteria.

Main Methods:

  • Retrospective assessment of MC characteristics in institutional patient cohorts.
  • Development of a semiquantitative diagnostic point scale.
  • Validation of the score using literature data and logistic regression/ROC curve analysis.

Main Results:

  • The developed scoring system incorporates thermoregulatory, neurological, cardiovascular, gastrointestinal, and metabolic alterations, plus precipitating events.
  • A score ≥60 was diagnostic for MC in institutional and literature cohorts (100% sensitivity, 85.71% specificity).
  • Scores between 45-59 indicated patients at risk for MC, with significant predictive power (OR=1.09 per unit increase).

Conclusions:

  • A score of 60 or higher on the proposed scale is potentially diagnostic for myxedema coma.
  • Scores ranging from 45 to 59 suggest patients are at risk for developing MC.
  • This scoring system can aid clinicians in the early recognition and management of MC.